Jazz Pharmaceuticals JAZZ
NASDAQ JAZZ
$213.76 +5.33 (+2.56%)
At close: Oct 20, 2026 · 4:00 PM EDT

Jazz Pharmaceuticals (JAZZ) Divestments (2015)

Updated

Jazz Pharmaceuticals' Divestments was $53 million in FY2022.

Analysis

Jazz Pharmaceuticals (JAZZ) Divestments (2015) Analysis & Trends

From FY2012 onward, Jazz Pharmaceuticals has reported Divestments for 4 years.

  • The FY2022 figure marks the highest annual Divestments since FY2012.
  • Per Business Quant data, Divestments in earlier years was $14.26 million in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Divestments (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn -
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn -
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn -
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn -
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 62.00 Mn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn -
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn -
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn -
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn -
10 Jazz Pharmaceuticals 13.50 Bn 7.32 Bn 1.09 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2015 1.00 Mn
Mar 31, 2015 32.70 Mn
API Access

Jazz Pharmaceuticals Divestments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=divestments&ticker=JAZZ&period=max&api_key=YOUR_API_KEY